All newborn babies are ugly

Early stage cancer cures are ugly for a long time.   Pertuzumab failed as a single agent cure, succeeded in multi-agent therapy.   Everolimus failed as a single agent breast cancer drug, succeeded in multi-agent therapy.  Herceptin was almost cut by Genentech before clinical trials.  The list goes on and on.


Now here's another ugly one:

http://www.cancertodaymag.org/Spring2012/Pages/blocking-metastatic-disease.aspx?Page=1

"Despite Psap's promising start, however, Watnick cautions that the first clinical trials of any such drug in people are at least two years away. It's also possible that his passionate investment could turn out to be a false start: Researchers have found thousands of molecules connected in some way to the spread of cancer. Most of these molecules never turn into plausible targets for cancer treatment-though a select few continue to advance slowly toward becoming potential new therapies. " 

But the idea is an interesting one:  can you stop metastatic cancer by something made by nonmetastatic cancer?   The PI is looking for investors.